Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.35M Sell
9,605
-3,070
-24% -$1.38M 1.7% 18
2026
Q1
$5.53M Buy
12,675
+3,069
+32% +$1.45M 1.91% 19
2025
Q4
$4.91M Sell
9,606
-1,195
-11% -$583K 1.56% 20
2025
Q3
$5.15M Sell
10,801
-44
-0.4% -$22.2K 1.63% 21
2025
Q2
$5.44M Sell
10,845
-299
-3% -$138K 1.84% 22
2025
Q1
$5.19M Sell
11,144
-45
-0.4% -$21.7K 2.02% 21
2024
Q4
$5.3M Buy
11,189
+237
+2% +$113K 1.84% 18
2024
Q3
$5.2M Buy
10,952
+1,576
+17% +$730K 1.87% 17
2024
Q2
$3.95M Buy
9,376
+1,617
+21% +$643K 1.46% 22
2024
Q1
$3.05M Buy
+7,759
New +$2.99M 1.11% 30

Other funds holding MCO

Altrafin AG's MCO Position: Q2 2026 in Review

Altrafin AG reduced its Moody's (MCO) stake by 24% in Q2 2026, selling an estimated $1.38M and leaving 9,605 shares worth $4.35M. The position accounts for 1.7% of the portfolio, ranked #18.

Altrafin AG first reported a position in MCO in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.53M in Q1 2026. 226 funds tracked by Wall St. Rank hold MCO as of Q2 2026.

  • Altrafin AG held 9,605 shares of Moody's worth $4.35M as of Q2 2026.
  • Altrafin AG sold 3,070 Moody's shares in Q2 2026, an estimated $1.38M.
  • Moody's made up 1.7% of Altrafin AG's portfolio in Q2 2026, its #18 holding.
  • Altrafin AG first reported a position in Moody's in Q1 2024 and has held it in 10 quarters since.
  • Altrafin AG's Moody's position peaked at $5.53M in Q1 2026.
  • 226 funds tracked by Wall St. Rank held Moody's as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.